In this episode of the RevGenetics Podcast, Les and Amy explore a cutting-edge breakthrough in cellular health: the use of nanotechnology to neutralize "zombie cells" after chemotherapy.
While chemotherapy is a vital tool in fighting cancer, it often leaves behind senescent cells—damaged cells that refuse to die. These "zombie cells" act like tiny factories, leaking toxins and inflammatory markers like interleukin-6 and interleukin-8, which can lead to chronic inflammation and even increase the risk of cancer recurrence.
We dive into a groundbreaking doctoral dissertation, "The Influence of Fisetin-Loaded Liposomes on Therapy-Induced Senescent Cells," which examines a powerful solution: Fisetin. While this natural compound found in fruits is a potent senolytic, it is notoriously difficult for the body to absorb because it is water-insoluble.
The game-changer? Nanotechnology. By using liposomes for precise delivery, researchers are finding ways to target these harmful toxins directly, offering a new path to combat the side effects of therapy-induced senescence and promote long-term recovery.
Join us as we unpack how high-tech delivery systems and natural compounds are joining forces to redefine post-therapy wellness.
Supported by RevGenetics – Science-Based Supplements For Healthy Aging
👉 Explore Longevity Products
Referenced Study:
🔗 The influence of fisetin-loaded liposomes on therapy-induced senescent cells
#Fisetin #LongevityResearch #CellularHealth #HealthyAging #Senolytic #RevGenetics #ZombieCells #Nanotechnology #CancerRecovery #AntiAgingScience #DeepDivePodcast #Interleukin6 #LiposomalDelivery #ScienceBreakthroughs #CellularSenescence #BioHacking #WellnessInnovation #PostChemoHealth #RevGeneticsSupport